AB SCIENCE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.906 EUR | -1.75% |
|
-4.22% | -46.39% |
| Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
| Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Chart calendar AB Science
669890cc875941bc1af61199ba411.HLEJEPRC2mEgYLCKOCYb3VdJwfGPbyLyyRi3UapBy7Y.c-BFc8MDkRBHId6zXBZpjjl_lKOiF0PLsyqaPJwxhcda-z5zgjXpNRQS3w~c14f4da128cb26f57f94ab4d27131e72
Upcoming events on AB Science
Past events on AB Science
| 2024-03-04 12:30 pm | Business Update Call |
| 2023-11-30 09:00 am | Business Update Call |
| 2023-09-29 01:49 pm | Q2 2023 Earnings Release |
| 2023-06-30 09:30 am | Annual General Meeting |
| 2023-05-15 | ALS Drug Development Summit |
| 2023-04-28 12:41 pm | Q4 2022 Earnings Release |
| 2023-03-16 01:00 pm | AB8939 Phase 1/2 Study Results Call |
| 2022-09-30 12:39 pm | Interim 2022 Earnings Release |
| 2022-05-23 | ALS Drug Development Summit |
| 2022-04-29 12:33 pm | FY 2021 Earnings Release |
| 2022-02-28 12:00 pm | Business Update Call |
| 2021-12-06 | International Symposium on ALS/MND |
| 2021-09-30 01:21 pm | Interim 2021 Earnings Release |
| 2021-09-11 | American Urological Association Meeting - Study AB12003 |
| 2021-07-29 10:00 am | Alzheimers Association International Conference |
| 2021-06-29 | Shareholders Meeting |
| 2021-06-04 09:00 am | American Society of Clinical Oncology Conference |
| 2021-06-03 12:30 pm | Masitinib Clinical Study Suspension Call |
| 2021-05-25 12:30 pm | Investor Meeting - Key Opinion Leader |
| 2021-04-30 12:45 pm | FY 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,70 | 1,57 1,55 1.65% | 1,58 | 0,00 | 0,93 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | -19,1 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -17,5 -21,4 18.17% | 0,00 | 0,00 | -16,0 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -13,6 | -19,6 |
|
EPS EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -0,29 | -0,38 |
| Announcement Date | 30/04/19 | 30/04/20 | 30/04/21 | 01/03/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,79 0,70 13% | 0,78 0,80 -2.5% | 0,81 0,90 -10.33% |
|
EBIT Million EUR | Released Forecast Spread | -10,6 -14,6 27.54% | -6,90 -10,8 36% | |
| Announcement Date | 30/09/19 | 30/04/20 | 30/09/20 |
More events
Past sector events for AB Science
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AB Stock
- Calendar AB Science
